Corcept Therapeutics Incorporated (CORT) Profit Margin
Corcept Therapeutics Incorporated (CORT) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 10.01% |
| 2017-12-31 | 81.11% |
| 2018-12-31 | 30.01% |
| 2019-12-31 | 30.73% |
| 2020-12-31 | 29.96% |
| 2021-12-31 | 30.74% |
| 2022-12-31 | 25.24% |
| 2023-12-31 | 22.00% |
| 2024-12-31 | 20.92% |
| 2025-12-31 | 13.09% |
How CORT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| MRK | Merck & Company Inc. | 28.08% |
| HAE | Haemonetics Corporation | 7.29% |
| VCEL | Vericel Corporation | 5.98% |
| MNKD | MannKind Corporation | 1.68% |
| NEOG | Neogen Corporation | -0.91% |
These are five companies in the same sector as CORT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("CORT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CORT | $112.18 | +0.29% | 0.65M |
| 3 | ||||
| 4 | ||||
| 5 |